Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trialGlenda Gray, Mookho Malahleha, Ollivier Hyrien et al.|The Lancet Infectious Diseases|2024Cited by 40
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is VaccinatedDean Follmann, Kathleen M. Neuzil, Jonathan Fintzi et al.|Annals of Internal Medicine|2021Cited by 26
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy TrialsDean Follmann, Kathleen M. Neuzil, Jonathan Fintzi et al.|medRxiv|2020Cited by 25